Drug intelligence / Profile preview

brain protein hydrolysate

Development stage
Unknown
Lead developer
Suzhong Pharmaceutical
Modality
Peptides
Administration
Intravenous
01

Overview

Funao Su is a brand name for Brain Protein Hydrolysate Injection, a neurotrophic biologic developed and manufactured by Jiangsu Suzhong Pharmaceutical Group. Derived from porcine brain tissue, it consists of a complex mixture of low-molecular-weight peptides and free amino acids capable of crossing the blood-brain barrier. The drug exerts neuroprotective and neuroreparative effects by promoting neuronal protein synthesis, improving cerebral energy metabolism, and protecting neurons against hypoxia and toxic insults. It is primarily used in China for the treatment of ischemic stroke (cerebral infarction), traumatic brain injury, and cognitive impairment following cerebrovascular accidents. Clinical studies, such as CTR20150799, have evaluated its safety and pharmacokinetics in healthy volunteers to support further clinical development and regulatory compliance.

Brand names
Funao Su
Other names
Brain Protein Hydrolysate Injection脑蛋白水解物注射液

Beyond the preview

Go deeper on brain protein hydrolysate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on brain protein hydrolysate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call